JBIO vs INVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

JBIO

52.1
AI Score
VS
JBIO Wins

INVA

48.4
AI Score

Investment Advisor Scores

JBIO

52score
Recommendation
HOLD

INVA

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JBIO INVA Winner
Net Income -40.37M 271.17M INVA
Operating Income -43.45M 163.75M INVA
ROE -13.6% 23.1% INVA
ROA -12.6% 16.6% INVA
Total Assets 319.43M 1.64B INVA
Cash 55.09M 550.94M INVA
Current Ratio 14.29 14.64 INVA
Free Cash Flow -24.28M 195.80M INVA

Relative Price Performance (Last 90 Days)

JBIO 1M: -11.0% · 3M: -21.0% INVA 1M: -6.9% · 3M: -10.1%

Current Technical Phase

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 42

RSI (14): 42.1 · Price: $19.15

INVA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 37

RSI (14): 36.9 · Price: $20.77

Fundamentals Snapshot

Metric JBIO INVA
Market Cap
Forward P/E -8.7 9.4
Trailing P/E 3.3
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.7%
Operating Margin 0.0% 0.4%
EPS -2.72 6.26
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.